2-[18F]-F-A85380

RADIATION2 trials

Sponsors

AstraZeneca

Conditions

Healthy

Phase 1

Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects

CompletedNCT00686413

AstraZenecaHealthy

Start: 2008-01-31End: 2008-08-31Updated: 2010-12-10

Positron Emission Tomography (PET) Study

CompletedNCT00886067

AstraZenecaHealthy

Start: 2009-04-30End: 2009-08-31Updated: 2009-09-10